Suppressive function of RKTG on chemical carcinogen-induced skin carcinogenesis in mouse

Carcinogenesis

Volumn 29, Issue 8, 2008, Pages 1632-1638

  Xie, Xiaoduo ^a   Zhang, Yixuan ^a   Jiang, Yuhui ^a   Liu, Weizhong ^a   Ma, Hong ^a   Wang, Zhenzhen ^a   Chen, Yan ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CARCINOGEN; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; RAF KINASE TRAPPING TO GOLGI; RAF PROTEIN; REGULATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER SIZE; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; EPIDERMIS HYPERPLASIA; GENE DISRUPTION; KERATINOCYTE; MALE; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SKIN CANCER; SKIN CARCINOGENESIS; SKIN PAPILLOMA;

ANIMALS; ANTICARCINOGENIC AGENTS; BROMODEOXYURIDINE; CARCINOGENS; CELL DIVISION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KERATINOCYTES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 49649127212     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn139     Document Type: Article

References (22)

1. Schubbert,S. et al. (2007) Hyperactive Ras in developmental disorders and cancer. Nat. Rev. Cancer, 7, 295-308.
2. Rapp,U.R. et al. (2006) BuCy RAFs drive cells into MEK addiction. Cancer Cell, 9, 9-12.
3. Hurst,E.A. et al. (2003) Ocular melanoma: A review and the relationship to cutaneous melanoma. Arch. Dermatol., 139, 1067-1073.
4. Khavari,P.A. (2006) Modelling cancer in human skin tissue. Nat. Rev. Cancer, 6, 270-280.
5. Green,C.L. et al. (2004) Targets for molecular therapy of skin cancer. Semin. Cancer Biol., 14, 63-69.
6. Mor,A. et al. (2006) Compartmentalized Ras/MAPK signaling. Annu. Rev. Immunol., 24, 771-800.
7. Harding,A. et al. (2005) Subcellular localization determines MAP kinase signal output. Curr. Biol., 15, 869-873.
8. Chiu,V.K. et al. (2002) Ras signalling on the endoplasmic reticulum and the Golgi. Nat. Cell Biol., 4, 343-350.
9. Rocks,O. et al. (2006) Spatio-temporal segregation of Ras signals: one ship, three anchors, many harbors. Curr. Opin. Cell Biol., 18, 351-357.
10. Bivona,T.G. et al. (2003) Phospholipase Cgamma activates Ras on the Golgi apparatus by means of RasGRP1. Nature, 424, 694-698.
11. Teis,D. et al. (2002) Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction. Dev. Cell, 3, 803-814.
12. Torii,S. et al. (2004) Sef is a spatial regulator for Ras/MAP kinase signaling. Dev. Cell, 7, 33-44.
13. Yeung,K. et al. (1999) Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature, 401, 173-177.
14. Wakioka,T. et al. (2001) Spred is a Sprouty-related suppressor of Ras signalling. Nature, 412, 647-651.
15. Sasaki,A. et al. (2003) Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1. Nat. Cell Biol. 5, 427-432.
16. Luttrell,L.M. et al. (2001) Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc. Natl Acad. Sci. USA, 98, 2449-2454.
17. Feng,L. et al. (2007) Spatial regulation of Raf kinase signaling by RKTG. Proc. Natl Acad. Sci. USA, 104, 14348-14353.
18. Kemp,C.J. (2005) Multistep skin cancer in mice as a model to study the evolution of cancer cells. Semin. Cancer Biol., 15, 460-473.
19. Quintanilla,M. et al. (1986) Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature, 322, 78-80.
20. Gonzalez-Garcia,A. et al. (2005) RalGDS is required for tumor formation in a model of skin carcinogenesis. Cancer Cell, 7, 219-226.
21. Bai,Y. et al. (2004) Crucial role of phospholipase Cepsilon in chemical carcinogen-induced skin tumor development. Cancer Res., 64, 8808-8810.
22. Shaw,A.T. et al. (2007) Sprouty-2 regulates oncogenic K-ras in lung evelopment and tumorigenesis. Genes Dev., 21, 694-707.